Cellbion Co., Ltd
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
308430 | KO
Overview
Corporate Details
- ISIN(s):
- KR7308430008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 종로구 대학로 103 서울대학교 암연구소 6층, 종로구
- Website:
- http://www.cellbion.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cellbion Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the research, development, and manufacturing of radiopharmaceuticals. The company focuses on advancing Radioligand Therapy (RLT) and antibody-based treatments to address unmet medical needs, particularly in oncology. Its pipeline includes diagnostic imaging agents for PET CT and therapeutic drugs, with a key program targeting Prostate-Specific Membrane Antigen (PSMA) for the diagnosis and therapy of prostate cancer. Cellbion operates a GMP-certified facility for the production of liquid and lyophilized injectable products, supporting both clinical trials and commercial supply.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-12 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청등결정) (전이성 거세 저항성 전립선암 환자에서 Lutetium(177Lu) …
|
Korean | 12.6 KB | ||
| 2025-09-09 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-09-04 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) (표준요법에 실패한 전이성 거세저항성 전립선암 환자에서 Lu177DGUL의 국내 …
|
Korean | 16.8 KB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-06-23 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (전이성 거세 저항성 전립선암 환자에서 Lutetium(177Lu) DGU…
|
Korean | 9.0 KB | ||
| 2025-05-13 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-03-31 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 23.1 KB | ||
| 2025-03-31 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 15.3 KB | ||
| 2025-03-31 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.9 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 460.8 KB | ||
| 2025-03-14 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 18.9 KB | ||
| 2025-03-11 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-02-28 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 11.8 KB | ||
| 2025-02-28 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 119.1 KB | ||
| 2025-01-31 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.5 KB |
Automate Your Workflow. Get a real-time feed of all Cellbion Co., Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cellbion Co., Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cellbion Co., Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
